Starpharma Holdings Ltd (SPL) — Capital Reinvestment Ratio

Latest as of December 2025: 0.06x

Starpharma Holdings Ltd (SPL) has a Capital Reinvestment Ratio of 0.06x as of December 2025, meaning it reinvests 0% of its operating cash flow (AU$3.91 Million) in capital expenditures (AU$237.00K). See SPL equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.06x

Capex / Operating Cash Flow

Operating Cash Flow

AU$3.91 Million

AUD

Capital Expenditures

AU$237.00K

AUD

Data as of

Dec 2025

Most recent filing

Annual Capital Reinvestment Ratio for Starpharma Holdings Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Starpharma Holdings Ltd from None to None. For live market cap and broader valuation context, see Starpharma Holdings Ltd market cap and net worth.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow